Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the United States – 2021
Updated Guidelines for Antiretroviral Post-Exposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV in the United States, 2016
HIV Prevention and Treatment Guidelines
Ending the HIV Epidemic in the US (EHE)
A federally sponsored initiative to accelerate progress in HIV prevention and end the HIV epidemic in the United States by 2030
National HIV Curriculum
AIDS Education and Training Center Program led by the University of Washington
As new PrEP products are approved by FDA, please be aware there may be a delay in resources and guideline updates
Connect With Our Medical Experts
Request a Scientific Discussion
Submit a request for additional information from a ViiV Medical Expert.
Report an Adverse Event
To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch
Are you a US healthcare provider?
This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.
If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.